GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinling Pharmaceutical Co Ltd (SZSE:000919) » Definitions » ROCE %

Jinling Pharmaceutical Co (SZSE:000919) ROCE % : 5.96% (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Jinling Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jinling Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 5.96%.


Jinling Pharmaceutical Co ROCE % Historical Data

The historical data trend for Jinling Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinling Pharmaceutical Co ROCE % Chart

Jinling Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.23 3.60 5.51 3.52 3.21

Jinling Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.38 4.29 2.63 -0.55 5.96

Jinling Pharmaceutical Co ROCE % Calculation

Jinling Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=118.652/( ( (4544.303 - 865.417) + (4550.523 - 839.898) )/ 2 )
=118.652/( (3678.886+3710.625)/ 2 )
=118.652/3694.7555
=3.21 %

Jinling Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=244.708/( ( (4550.523 - 839.898) + (5343.014 - 835.624) )/ 2 )
=244.708/( ( 3710.625 + 4507.39 )/ 2 )
=244.708/4109.0075
=5.96 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinling Pharmaceutical Co  (SZSE:000919) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Jinling Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Jinling Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinling Pharmaceutical Co (SZSE:000919) Business Description

Traded in Other Exchanges
N/A
Address
No. 238 Zhongyang Road, Jinling Pharmaceutical Building, Nanjing, Jiangsu, CHN, 210009
Jinling Pharmaceutical Co Ltd is a China-based pharmaceutical company.
Executives
Fan Jin Tian Director
Jia Ming Yi Executives
Li Quan Executives
Chen Sheng Executives
Xu Jun Yang Secretary Dong
Wang Yang Executives
Yin Jian Biao Executives
Li Jian Executives
Liang Yu Tang Directors, executives
Zhang Ning Executives
Li Chun Min Director
Sui Li Cheng Executives
Tang Wei Guo Directors, executives
Wang Suo Jin Executives
Shen Zhi Long Director

Jinling Pharmaceutical Co (SZSE:000919) Headlines

No Headlines